Medicalgorithmics S.A.
MDG.WA
Get informed when a big investor buys or sells
+ FollowMarket Cap$248.82M
Close$
$-16.93
167.7% downside
Current Fair Value
167.7% downsideOvervalued by 167.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $248.82 Million |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.17 |
| Beta | 0.63 |
| Outstanding Shares | 9,952,769 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -35.18 |
|---|---|
| PEG | 33.39 |
| Price to Sales | 8.33 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 29, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$11.00 M
Average shareholder expectationNext Earnings Call
Expected Date
November 26, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$10.73 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Medicalgorithmics S.A.
109 employees
CEO: Krzysztof Siemionow Established in 2005 and headquartered in Warsaw, Poland, Medicalgorithmics S.A. is a prominent provider of cardiac diagnostic solutions, serving markets in Poland, the United States, and globally. The company offers an array of advanced ...